PE20141530A1 - Composicion farmaceutica para uso en inflamacion y dolor - Google Patents

Composicion farmaceutica para uso en inflamacion y dolor

Info

Publication number
PE20141530A1
PE20141530A1 PE2013002871A PE2013002871A PE20141530A1 PE 20141530 A1 PE20141530 A1 PE 20141530A1 PE 2013002871 A PE2013002871 A PE 2013002871A PE 2013002871 A PE2013002871 A PE 2013002871A PE 20141530 A1 PE20141530 A1 PE 20141530A1
Authority
PE
Peru
Prior art keywords
pharmaceutical composition
inflammation
pain
composition
ketorolaco
Prior art date
Application number
PE2013002871A
Other languages
English (en)
Inventor
Paniagua Maria Angelica Arzola
Salgado Lopez Enrique Raul Garcia
Pelaez Juan Pablo Senosiain
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of PE20141530A1 publication Critical patent/PE20141530A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UNA COMBINACION FARMACEUTICA QUE COMPRENDE: A) UN ANTIINFLAMATORIO TAL COMO MELOXICAN O PIROXICAM; Y B) UN ANALGESICO TAL COMO KETOROLACO. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) 0.2g A 5g DE MELOXICAN O 0.5g A 20g DE PIROXICAM POR CADA 100g DE LA COMPOSICION; B) 0.1 A 10g DE KETOROLACO POR CADA 100g DE LA COMPOSICION; C) UN AGENTE GELIFICANTE SELECCIONADO DE POLIMEROS DE ACIDO VINILICO, LUTROL, HIDROXIPROPILCELULOSA, ENTRE OTROS; D) UN AGENTE TAL COMO ETANOLAMINAS QUE DISOCIA AL AGENTE GELIFICANTE, EL CUAL MANTIENE EL pH DE 7.0 A 10.0; Y VEHICULOS Y EXCIPIENTES FARMACEUTICAMENTE ACEPTABLES; LA COMPOSICION FARMACEUTICA SE PRESENTA EN FORMA DE GEL, CREMA, UNGUENTO, O PASTA. DICHAS COMBINACION Y COMPOSICION FARMACEUTICAS SON UTILES PARA EL TRATAMIENTO DE LA INFLAMACION Y EL DOLOR
PE2013002871A 2011-06-22 2012-06-21 Composicion farmaceutica para uso en inflamacion y dolor PE20141530A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011006758A MX357376B (es) 2011-06-22 2011-06-22 Composicion farmaceutica para uso en inflamacion y dolor.

Publications (1)

Publication Number Publication Date
PE20141530A1 true PE20141530A1 (es) 2014-11-12

Family

ID=47422093

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013002871A PE20141530A1 (es) 2011-06-22 2012-06-21 Composicion farmaceutica para uso en inflamacion y dolor

Country Status (13)

Country Link
AR (1) AR086733A1 (es)
BR (1) BR112013033007A2 (es)
CL (1) CL2013003671A1 (es)
CO (1) CO6831987A2 (es)
CR (1) CR20130687A (es)
DO (1) DOP2013000309A (es)
ES (1) ES2441917B1 (es)
GT (1) GT201300318A (es)
MX (1) MX357376B (es)
NI (1) NI201300142A (es)
PE (1) PE20141530A1 (es)
RU (1) RU2604149C2 (es)
WO (1) WO2012176155A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3025717B1 (en) * 2013-05-27 2018-11-07 Farmacéuticos Rayere, S.A. Synergistic pharmaceutical composition of two analgesics having a distinct pharmacokinetic profile

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5091182A (en) * 1990-07-23 1992-02-25 Syntex (U.S.A.) Inc. Dispensing units for ketorolac topical gel formlations
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
MXPA02010828A (es) * 2002-11-04 2004-07-16 Leopoldo Espinosa Abdala Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
RU2237470C1 (ru) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
MXPA04009698A (es) * 2004-10-04 2006-04-05 Maria Elena Garcia Armenta Formulaciones farmaceuticas solidas conteniendo diacereina y meloxicam.
WO2007148950A1 (es) * 2006-06-20 2007-12-27 Farmacéuticos Rayere, S.A. Composición farmacéutica sinergística de ketorolaco y clonixinato de lisina
MX2007003948A (es) * 2007-04-02 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination

Also Published As

Publication number Publication date
ES2441917B1 (es) 2014-11-25
CO6831987A2 (es) 2014-01-10
CL2013003671A1 (es) 2014-07-11
GT201300318A (es) 2015-05-21
WO2012176155A1 (es) 2012-12-27
ES2441917R1 (es) 2014-02-19
RU2604149C2 (ru) 2016-12-10
CR20130687A (es) 2014-02-21
AR086733A1 (es) 2014-01-15
MX357376B (es) 2018-07-06
NI201300142A (es) 2015-02-25
ES2441917A2 (es) 2014-02-06
DOP2013000309A (es) 2014-04-15
BR112013033007A2 (pt) 2017-01-31
RU2013157013A (ru) 2015-07-27
MX2011006758A (es) 2013-01-10

Similar Documents

Publication Publication Date Title
MX2015002239A (es) Formulacion oftalmica de lipido polioxilo o de acido graso polioxilo y tratamiento de padecimientos oculares.
MX2017016217A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
NZ727975A (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
AR068816A1 (es) Composiciones de brimonidina mejorada para el tratamiento del eritema
AR084932A1 (es) Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
PH12020550032A1 (en) Gel comprising chlorhexidine
MX2022008277A (es) Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas.
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
CL2008002747A1 (es) Compuestos derivados de furo y tienopirimidina; composicion farmaceutica; metodo para modular la actividad del receptor de histamina h4; y uso en el tratamiento de trastornos tales como inflamacion, trastornos alergicos, dermatologicos, entre otros.
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
MX2015017202A (es) Formulacion de liberacion modificada.
WO2014164285A3 (en) Use of levocetirizine and montelukast in the treatment of vasculitis
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
SG10201908690WA (en) Novel method of use and compositions
EA201491614A1 (ru) Способ лечения гинекологических заболеваний
PE20160850A1 (es) Sistema multiparticulado para administrar drogas
AR094224A1 (es) Composicion farmaceutica en forma de una suspension oral
PE20141530A1 (es) Composicion farmaceutica para uso en inflamacion y dolor
PH12015501538A1 (en) Topical ocular analgesic agents
MX2020003697A (es) Formulaciones farmaceuticas que comprenden un agonista del receptor opioide como ingredientes activos, metodos de fabricacion y usos terapeuticos de las mismas.
EP2570131A4 (en) PREPARATION LEISHMANICIDE AND USE THEREOF
AR086252A1 (es) Formulacion topica que comprende dipropionato de beclometasona como ingrediente activo

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
AE Restoration of lapsed or forfeited application
FC Refusal